Earnings Preview For Coherus BioSciences
Portfolio Pulse from Benzinga Insights
Coherus BioSciences (NASDAQ:CHRS) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.12. Historical data shows mixed reactions to past earnings, with significant price changes following the announcements. Shares have declined 63.34% over the last year, indicating investor concern ahead of this release.
March 12, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Coherus BioSciences is expected to report an EPS of $-0.12 for the upcoming quarter. Historical performance shows significant stock price volatility post-earnings, with a notable 63.34% decline over the past year.
Given the historical volatility in Coherus BioSciences' stock price following earnings announcements and the significant decline over the past year, it's likely that the upcoming earnings report could lead to further downward pressure on the stock price, especially if the company fails to meet or exceed the expected EPS or provides negative guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100